A prognostic score model to determine which breast cancer patients with 1-3 positive lymph nodes after modified radical mastectomy should receive radiotherapy

被引:3
|
作者
Chen, Dawei [1 ]
Wang, Haiyong [2 ]
Song, Xinyu [1 ,3 ]
Shi, Fang [1 ]
Kong, Li [1 ]
Yu, Jinming [1 ]
机构
[1] Shandong Univ, Shandong Acad Med Sci, Shandong Canc Hosp, Dept Radiat Oncol, Jinan, Shandong, Peoples R China
[2] Shandong Univ, Shandong Acad Med Sci, Shandong Canc Hosp, Dept Internal Med Oncol, Jinan, Shandong, Peoples R China
[3] Univ Jinan, Shandong Acad Med Sci, Sch Med & Life Sci, Jinan, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
breast cancer; postmastectomy radiotherapy; SEER; population-based study; LOCOREGIONAL RECURRENCE RISK; CLINICAL-PRACTICE GUIDELINES; 20-YEAR FOLLOW-UP; POSTMASTECTOMY RADIOTHERAPY; RANDOMIZED-TRIALS; T1-T2; TUMORS; RADIATION; IRRADIATION; THERAPY; SURGERY;
D O I
10.18632/oncotarget.21531
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
There is no consensus on the indication for postmastectomy radiotherapy (PMRT) in breast cancer patients with one to three positive lymph nodes. To identify patients for whom PMRT may be indicated, we used a prognostic score model with the SEER database to retrospectively analyze 8049 patients with one to three positive lymph nodes who underwent mastectomy with or without PMRT between 2010 and 2013. Kaplan-Meier analysis showed that PMRT patients had better overall survival (OS) than no-PMRT patients (P < 0.001); however, there was no difference in cancer-specific survival (CSS) (P = 0.530). Multivariate analysis with Cox regression showed that grade (P < 0.001), tumor size (P < 0.001), and progesterone receptor status (P < 0.001) were independent prognostic factors for OS. To diminish bias, we used 1: 1 propensity score matching analysis and prognosis score model, which revealed that PMRT patients had better OS and CSS than no-PMRT patients (P < 0.001). In a concrete subgroup analysis of PMRT patients, significant improvements in OS were observed in patients scoring 0, 1, or 2. PMRT patients scoring 2 also had improved CSS. The magnitude of the OS and CSS difference with PMRT correlated with the prognostic score (P < 0.001). These results suggest PMRT in breast cancer patients with one to three positive lymph nodes should be based on patient factors, tumor biology, and prognostic score.
引用
收藏
页码:385 / 393
页数:9
相关论文
共 50 条
  • [1] Should Postmastectomy Radiotherapy to the Chest Wall and Regional Lymph Nodes Be Standard for Patients with 1-3 Positive Lymph Nodes?
    Offersen, Birgitte V.
    Brodersen, Hans-Juergen
    Nielsen, Mette M.
    Overgaard, Jens
    Overgaard, Marie
    BREAST CARE, 2011, 6 (05) : 347 - 351
  • [2] The role of post-mastectomy radiotherapy in elderly patients with 1-3 positive lymph nodes breast cancer: An International Retrospective Double-Center Study
    Cao, Lu
    Adedjouma, Noemie G.
    Xu, Cheng
    Shen, Kun-Wei
    Laki, Fatima
    Chen, Jia-Yi
    Kirova, Youlia M.
    BREAST JOURNAL, 2019, 25 (01) : 107 - 111
  • [3] Should all breast cancer patients with four or more positive lymph nodes who underwent modified radical mastectomy be treated with postoperative radiotherapy? A population-based study
    Wang, Haiyong
    Kong, Li
    Zhang, Chenyue
    Chen, Dawei
    Zhu, Hui
    Yu, Jinming
    ONCOTARGET, 2016, 7 (46) : 75492 - 75502
  • [4] Efficacy and Survival Analysis of Radiotherapy for Internal Mammary Lymph Nodes After Modified Radical Mastectomy for T 1-3 N 3 M 0 the Lateral Quadrant Breast Cancer
    Han, Xiumei
    Jiang, Die
    Zhu, Chaomang
    Li, Duojie
    Yin, Hongmei
    BREAST CANCER-TARGETS AND THERAPY, 2024, 16 : 811 - 823
  • [5] Prognostic factors for breast cancer patients with T1-2 tumor and 1-3 positive axillary nodes treated using total mastectomy without radiotherapy
    Asaga, Sota
    Kinoshita, Takayuki
    Shiino, Shou
    Jimbo, Kenjiro
    Takayama, Shin
    BREAST JOURNAL, 2019, 25 (01) : 26 - 33
  • [6] Real-world outcomes of postmastectomy radiotherapy in breast cancer patients with 1-3 positive lymph nodes: a retrospective study
    Chitapanarux, Imjai
    Tharavichitkul, Ekkasit
    Jakrabhandu, Somvilai
    Klunklin, Pitchayaponne
    Onchan, Wimrak
    Srikawin, Jirawattana
    Pukanhaphan, Nantaka
    Traisathit, Patrinee
    Vongtama, Roy
    JOURNAL OF RADIATION RESEARCH, 2014, 55 (01) : 121 - 128
  • [7] Role of adjuvant Radiotherapy after Mastectomy and Axillary Dissection in Breast Cancer with Involvement of 1-3 Lymph Nodes
    Becker-Schiebe, M.
    Hoffmann, W.
    ONKOLOGE, 2014, 20 (07): : 687 - 688
  • [8] Locoregional Recurrence Risk for Patients With T1,2 Breast Cancer With 1-3 Positive Lymph Nodes Treated With Mastectomy and Systemic Treatment
    McBride, Andrew
    Allen, Pamela
    Woodward, Wendy
    Kim, Michelle
    Kuerer, Henry M.
    Drinka, Eva Katherine
    Sahin, Aysegul
    Strom, Eric A.
    Buzdar, Aman
    Valero, Vicente
    Hortobagyi, Gabriel N.
    Hunt, Kelly K.
    Buchholz, Thomas A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 89 (02): : 392 - 398
  • [9] Postoperative periclavicular radiotherapy in breast cancer patients with 1-3 positive axillary lymph nodes Outcome and morbidity
    Biancosino, A.
    Bremer, M.
    Karstens, J. H.
    Biancosino, C.
    Meyer, A.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (05) : 417 - 423
  • [10] A Prognostic Risk Stratification Model to Identify Potential Population Benefiting From Postmastectomy Radiotherapy in T1-2 Breast Cancer With 1-3 Positive Axillary Lymph Nodes
    Hou, Niuniu
    Zhang, Juliang
    Yang, Lu
    Wu, Ying
    Wang, Zhe
    Zhang, Mingkun
    Yang, Li
    Hou, Guangdong
    Wu, Jianfeng
    Wang, Yidi
    Dong, Bingyao
    Guo, Lili
    Shi, Mei
    Ling, Rui
    FRONTIERS IN ONCOLOGY, 2021, 11